Business
ASX 200 expected to drop lower amid COVID-19 vaccine concerns
The S&P/ASX 200 Index (ASX: XJO) is expected to drop lower this morning, with SPI futures currently pointing to a 0.3% decline at the open.
This decline appears to have been driven by concerns over the AstraZeneca-Oxford University COVID-19 vaccine candidate, AZD1222.
What has happened?
Last week AstraZeneca revealed that its phase three trial data showed that its vaccine candidate was highly effective against COVID-19 with certain dosages.
The data showed that when trial participants were given a half dose, followed by a full dose at least one month apart, the vaccine was 90% effective. Whereas, when given as two full doses at least one month apart, the vaccine showed just 62% efficacy.
Overnight, the pharmaceutical giant…
-
General19 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News18 hours agoMitch Power Quick Shear event gets men talking about mental health
-
Business18 hours agoAdd these 2 satellite ETFs to your core ASX stock portfolio
-
General21 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why